The Leukemia & Lymphoma Society Available to Offer Its Expertise in Light of Death of 60 Minutes' Ed Bradley

The Leukemia & Lymphoma Society Available to Offer Its Expertise in Light of Death of 60 Minutes' Ed Bradley

Available to Comment

WHITE PLAINS, N.Y., Nov. 9 /PRNewswire/ -- The Leukemia & Lymphoma Society is available to comment on chronic lymphocytic leukemia -- the type of leukemia that caused the death of veteran CBS newsman Ed Bradley today. Bradley, an anchor on CBS's 60 Minutes, was 65.

The Society can address the particulars of chronic lymphocytic leukemia -- the symptoms, treatment options and information on where to turn for help.

To arrange interviews contact Andrea Greif at 914-821-8958 or 914-772-3027 (cell phone), or email andrea.greif@lls.org.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY, with 66 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The Society's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, the Society has invested more than $483 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, the Society made 4.2 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit www.LLS.org or call the Society's Information Resource Center (IRC), a call center staffed by master's level social workers, nurses and health educators who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

Source: The Leukemia & Lymphoma Society

CONTACT: Andrea Greif, +1-914-821-8958, or +1-914-772-3027 (cell phone),
andrea.greif@lls.org

Web site: http://www.lls.org/

-------
Profile: intent